Corcept Therapeutics reported $411.27M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 645.73M 28.25M
Ani Pharmaceuticals ANIP:US $ 191.8M 9M
Aphria Inc APH:CN C$ 730.7M 38.56M
Ardelyx ARDX:US $ 186.49M 18.88M
Aurora Cannabis Inc ACB:CN 665.89M 108.33M
Biodelivery Sciences International BDSI:US $ 196.06M 9.92M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Canopy Growth Corp WEED:CN C$ 2.68B 163.02M
Corcept Therapeutics CORT:US $ 411.27M 1.65M
Depomed DEPO:US $ 119.35M 4.72M
Eleven Biotherapeutics EBIO:US 175.1M 48.52M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Esperion Therapeutics ESPR:US $ 275.17M 2.6M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Knight Therapeutics Inc GUD:CN C$ 330.03M 220.05M
Lannett LCI:US $ 353.56M 16.35M
Merk MRK:US $ 28665M 1756M
Nektar Therapeutics NKTR:US $ 1056.15M 42.9M
Novartis NOVN:VX 23.81B 1.61B
Novartis NVS:US $ 26253M 2445M
Omeros OMER:US $ 112.4M 20.08M
Pacira Pharmaceuticals PCRX:US $ 792.58M 72.33M
Supernus Pharmaceuticals SUPN:US $ 639.24M 53.22M
Ziopharm Oncology ZIOP:US $ 89.41M 23.3M